Nina Magnolo, Michael C. Cameron, Mona Shahriari, Bob Geng, Brian M. Calimlim, Henrique Teixeira, . . . Richard G. Langley. (2024). Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up study. Taylor & Francis Group.
Chicago Style (17th ed.) CitationNina Magnolo, et al. Rapid and Sustained Improvements in Itch and Quality of Life with Upadacitinib Plus Topical Corticosteroids in Adults and Adolescents with Atopic Dermatitis: 52-week Outcomes from the Phase 3 AD Up Study. Taylor & Francis Group, 2024.
MLA (9th ed.) CitationNina Magnolo, et al. Rapid and Sustained Improvements in Itch and Quality of Life with Upadacitinib Plus Topical Corticosteroids in Adults and Adolescents with Atopic Dermatitis: 52-week Outcomes from the Phase 3 AD Up Study. Taylor & Francis Group, 2024.